ARTICLE SUMMARY:
Promaxo is advancing an office-based detection system for prostate cancer with the benefits of MRI in terms of high specificity and sensitivity, but at a fraction of the cost of traditional MRI machines, while also eliminating the need for invasive and uncomfortable internal components.
When it comes to the detection of prostate cancer, our current options leave quite a bit to be desired.
